Clinical trials
Phase 1/2 Arthritis, Rheumatoid trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Antares Pharma Inc. | 1 |
| Children's Hospital of Philadelphia | 1 |
| Crystal Lederhos Smith | 1 |
| Cura Biotech LLC | 1 |
| Eli Lilly and Company | 1 |
| Fate Therapeutics | 1 |
| Harbor Therapeutics | 1 |
| Hope Biosciences LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 24 |
| Lupus Erythematosus, Systemic | 4 |
| Arthritis | 3 |
| Autoimmune Diseases | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 |
| Myositis | 2 |
| Scleroderma, Systemic | 2 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Arthritis, Juvenile | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.